• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Dermatology

Topical corticosteroid use in pregnancy not associated with increased risk of small for gestational age or low birth weight newborns

byYuchen DaiandMichael Pratte
June 2, 2021
in Dermatology, Obstetrics, Pediatrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. No association was found between topical corticosteroid use during pregnancy and increased risks of newborns being small for gestational age (SGA) or having low birth weight, regardless of corticosteroid potency and amount used.

Evidence Rating Level: 2 (Good)

Study Rundown: Topical corticosteroids are frequently used during pregnancy for various dermatological conditions such as eczema. However, data to help evaluate potential fetal harm from topical corticosteroid use in pregnancy are limited and conflicting, in particular with the use of potent to very potent agents. The most recent guidelines recommend the use of topical corticosteroids with mild to moderate potency in pregnancy, whereas potent to very potent agents should be reserved as second-line therapy and used only for a short period. This large cohort study using data from the Danish Medical Birth Registry sought to evaluate whether topical corticosteroid use in pregnancy was associated with increased risks of small for gestational age (SGA) and low birth weight. The primary outcomes were SGA and low birth weight, where associations between outcomes and exposure was assessed via relative risk ratios and absolute risk differences. From a source cohort of 1.1 million live birth singleton pregnancies in Denmark (1997-2016) eligible for study inclusion, 60,497 pregnancies were exposed to topical corticosteroids. This was matched with 241,986 unexposed pregnancies on the basis of propensity scores, including a wide set of baseline characteristics. In the cohort exposed to topical corticosteroids during pregnancy, 5,678 (9.4%) of the delivered infants were born SGA in contrast to 22,634 infants (9.4%) among the matched unexposed pregnancies. Low birth weight occurred in 2,006 (3.3%) of the exposed pregnancies compared to 8,675 (3.6%) of the unexposed pregnancies. Analysis showed that exposure to potent to very potent topical corticosteroids at any amount was not associated with an increased risk of SGA or low birth weight. A limitation of this study and potential source of confounding includes patient cases where the underlying indication being treated, rather than the treatment itself, increases the risk of the outcome (i.e., confounding by indication). Although the study found no significant increased risk in any of the analyses, residual confounding cannot be excluded.

Click to read the study in JAMA Dermatology

Relevant Reading: Pregnancy outcomes after maternal exposure to topical corticosteroids: a UK population-based cohort study

In-Depth [retrospective cohort]: This nationwide cohort study included all pregnancies resulting in live births identified via the Danish Medical Birth Registry from January 1997 to December 2016. From an initial source cohort of 1.1 million live birth singleton pregnancies, a total of 60,497 pregnancies exposed to topical corticosteroids were matched with 241,986 unexposed pregnancies to be included in this study. The median gestational age at first filled prescription for a topical corticosteroid was day 112 (IQR, 44-181 days), with a median received amount of 30 g (IQR, 30-60 g; mean, 53.6 g). A total of 27,630 pregnant women had filled prescriptions for potent to very potent topical corticosteroids (median received amount, 30 g; IQR, 25-80 g; mean, 68.9 g). Among 60,497 pregnancies in the exposed cohort, 5,678 infants (9.4%) were born SGA compared with 22,634 infants (9.4%) in the matched unexposed cohort (RR, 1.00; 95%CI, 0.98-1.03 and ARD, 0.3; 95%CI, -2.3 to 2.9 per 1000 pregnancies). Low birth weight occurred in 2,006 (3.3%) of the exposed pregnancies compared with 8,675 (3.6%) of the unexposed pregnancies (RR, 0.92; 95%CI, 0.88-0.97 and ARD, -2.7; 95%CI, -4.3 to -1.1 per 1000 pregnancies). Furthermore, exposure to potent to very potent topical corticosteroids at any amount was not associated with an increased risk of SGA (RR, 1.03; 95%CI, 0.99-1.07) or low birth weight (RR, 0.94; 95%CI, 0.88-1.00). Lastly, post hoc analyses did not find a significant increased risk among those receiving large amounts of potent to very potent topical corticosteroids throughout pregnancy compared with unexposed pregnancies (RR, 1.17; 95%CI, 0.95-1.46 for SGA and RR 1.14; 95%CI, 0.81-1.60 for low birth weight).

Image: PD

RELATED REPORTS

Wellness Check: Sleep

Vitamin C supplementation in pregnant smokers leads to improved airway function in offspring

Wellness Check: Nutrition

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: adverse pregnancy outcomescorticosteroidslow birth weightpregnancysmall for gestational age
Previous Post

Special Report: Psychedelics in Medicine Part 2: Psychedelics for depression & trauma-related disorders

Next Post

Tocilizumab may improve survival in COVID-19 patients with hypoxia and systemic inflammation 

RelatedReports

Decline in adolescent sleep duration over past 20 years
Wellness

Wellness Check: Sleep

January 19, 2023
2 Minute Rewind November 29, 2021
Obstetrics

Vitamin C supplementation in pregnant smokers leads to improved airway function in offspring

December 28, 2022
Dietary variety linked to greater increase in childhood BMI
Wellness

Wellness Check: Nutrition

December 28, 2022
2 Minute Rewind November 29, 2021
Obstetrics

COVID-19 increased anxiety rates during the perinatal period and pregnancy

December 14, 2022
Next Post
Decreased expression of nasal ACE2 may be correlated with lower prevalence of COVID-19 in children

Tocilizumab may improve survival in COVID-19 patients with hypoxia and systemic inflammation 

Patients with low back pain or pain at multiple sites at highest risk for chronic opioid use

Weekly and monthly subcutaneous buprenorphine associated with improved treatment satisfaction versus daily sublingual administration in opioid dependence

#VisualAbstract: Sonelokimab showed significant clinical benefit over placebo in patients with plaque psoriasis

#VisualAbstract: Sonelokimab showed significant clinical benefit over placebo in patients with plaque psoriasis

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Higher body mass index may be associated with altered vitamin D levels and metabolism
  • #VisualAbstract: Torsemide does not provide additional decrease in mortality compared to furosemide among patients hospitalized for heart failure
  • Community-based adult vision screening program increases access to eye care
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options